Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Bennett, Charles
One or more keywords matched the following items that are connected to Bennett, Charles
Item TypeName
Concept Erythropoietin
Concept Receptors, Erythropoietin
Academic Article Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.
Academic Article Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome.
Academic Article Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries.
Academic Article Pure red-cell aplasia and epoetin therapy.
Academic Article The blue cross blue shield assessment technology review: summary of findings.
Academic Article Effectiveness of erythropoietin in the treatment of patients with malignancies: methods and preliminary results of a Cochrane review.
Academic Article Clinical characteristics of erythropoietin-associated pure red cell aplasia.
Academic Article Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group.
Academic Article Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis.
Academic Article Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project.
Academic Article Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.
Academic Article Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update.
Academic Article Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update.
Academic Article Does reimbursement affect physicians' decision making? Examples from the use of recombinant erythropoietin.
Academic Article Epoetin-associated pure red cell aplasia: past, present, and future considerations.
Academic Article Cancer- and chemotherapy-induced anemia.
Academic Article American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.
Academic Article American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.
Academic Article Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR).
Academic Article Caveat oncologist: clinical findings and consequences of distributing counterfeit erythropoietin in the United States.
Academic Article A review of safety, efficacy, and utilization of erythropoietin, darbepoetin, and peginesatide for patients with cancer or chronic kidney disease: a report from the Southern Network on Adverse Reactions (SONAR).
Academic Article Emerging drugs for treatment of anemia of chronic kidney disease.
Academic Article Forewarned is forearmed: erythropoietin use in CKD patients with cancer.
Academic Article Erythropoietin, a novel repurposed drug: an innovative treatment for wound healing in patients with diabetes mellitus.
Academic Article Erythropoiesis-stimulating agents and quality of life: personal journeys of a cancer survivor, oncologist, and two cancer health services researchers.
Academic Article Consensus on the Existence of Functional Erythropoietin Receptors on Cancer Cells.
Academic Article The FDA Black Box Warning Does Reduce the Use of Erythropoietin Stimulating Agents and Increases Blood Transfusions in Insured, Low Income Cancer Patients.
Academic Article Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced Anemia.
Academic Article Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology.
Academic Article Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions.
Search Criteria
  • Erythropoietin